BRIUMVI 150 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
BRIUMVI 150 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Commercialized
Register Number
1231730001
Prescription Type
Uso Hospitalario
Authorization Date
Nov 14, 2023
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Route: VÍA INTRAVENOSA
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1231730001
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
UBLITUXIMABActive
Quantity: 150 mg
Name: UBLITUXIMAB
ATC CLASSIFICATION (3)
L04A
L04AG
L04AG14